These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 9916343)
1. [Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents]. Caen J; Bellucci S Bull Acad Natl Med; 1998; 182(7):1493-502; discussion 1502-3. PubMed ID: 9916343 [TBL] [Abstract][Full Text] [Related]
2. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease. Clemetson KJ; Clemetson JM Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310 [TBL] [Abstract][Full Text] [Related]
3. Platelet-vessel wall interaction: from the bedside to molecules. Caen JP; Rosa JP Thromb Haemost; 1995 Jul; 74(1):18-24. PubMed ID: 8578453 [TBL] [Abstract][Full Text] [Related]
4. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402 [TBL] [Abstract][Full Text] [Related]
5. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and molecular basis of Glanzmann's thrombasthenia. Perutelli P; Mori PG Haematologica; 1992; 77(5):421-6. PubMed ID: 1483593 [TBL] [Abstract][Full Text] [Related]
15. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells. Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479 [TBL] [Abstract][Full Text] [Related]
16. Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis? Nurden AT; Nurden P; George JN Adv Exp Med Biol; 2001; 489():13-29. PubMed ID: 11554587 [No Abstract] [Full Text] [Related]
17. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function. Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548 [TBL] [Abstract][Full Text] [Related]
18. [Platelet aggregations and glycoproteins]. Yamamoto N; Arai M; Tanoue K Rinsho Byori; 1992 Mar; 40(3):272-81. PubMed ID: 1518178 [TBL] [Abstract][Full Text] [Related]
19. Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome. Strassel C; Nonne C; Eckly A; David T; Leon C; Freund M; Cazenave JP; Gachet C; Lanza F Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):241-7. PubMed ID: 17095718 [TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of the Bernard-Soulier syndrome, platelet-type von Willebrand's disease and Glanzmann's thrombasthenia. Clemetson KJ; Clemetson JM Beitr Infusionsther; 1993; 31():168-73. PubMed ID: 7693249 [No Abstract] [Full Text] [Related] [Next] [New Search]